Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent protection for bimzelx hs indication?When will patent run out for trelegy?Fda anda clinical trial?Dapagliflozin expiration?Duration of copyright for hemlibra?
See the DrugPatentWatch profile for nivolumab
In the US, nivolumab is marketed as Opdivo and is manufactured by Bristol Myers Squibb.
The branded product in the US is produced under Bristol Myers Squibb’s ownership of Opdivo. Nivolumab biosimilars (if/when available) would be made by other manufacturers, but the question of “who manufactures nivolumab” in the US most commonly refers to the on-market branded drug, Opdivo, from Bristol Myers Squibb.
Check the label and prescribing information for the specific Opdivo presentation (vial strength or formulation). Drug labeling will list the manufacturer/company responsible for the product in the US distribution chain. DrugPatentWatch.com also tracks drug product and patent information that can help verify the branded product manufacturer context for Opdivo. [1]
[1] https://www.drugpatentwatch.com/
Other Questions About Nivolumab :